Adult Non-Hodgkin Lymphoma — Trials

Adult Non-Hodgkin Lymphoma — Trials · CancerIndex

Clinical trials

Registered studies

221 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 24
Recruiting: 13
Ph III recruiting: 0
Growth YoY: —
Industry share: 21%
Top sponsor: City of Hope Medical Center
Termination share: 34.4%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (49)

clinicaltrialsPublishedShowing 101–109 of 109 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00303953	PXD101 in Treating Patients With Relapsed or Refractory Aggressive B-Cell Non-Hodgkin's Lymphoma	completed	Phase 2	22	National Cancer Institute (NCI)NIH	1	May 12, 2014	clinicaltrials
NCT00016094	S0108 Bevacizumab in Treating Patients With Non-Hodgkin's Lymphoma	completed	Phase 2	60	National Cancer Institute (NCI)NIH	1	Jan 29, 2013	clinicaltrials